CN104341433B - A kind of preparation method of prasugrel intermediate - Google Patents

A kind of preparation method of prasugrel intermediate Download PDF

Info

Publication number
CN104341433B
CN104341433B CN201310335239.XA CN201310335239A CN104341433B CN 104341433 B CN104341433 B CN 104341433B CN 201310335239 A CN201310335239 A CN 201310335239A CN 104341433 B CN104341433 B CN 104341433B
Authority
CN
China
Prior art keywords
compound
preparation
prasugrel
reacts
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310335239.XA
Other languages
Chinese (zh)
Other versions
CN104341433A (en
Inventor
赵志全
白文钦
张�杰
李迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lunan Pharmaceutical Group Corp
Original Assignee
Lunan Pharmaceutical Group Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunan Pharmaceutical Group Corp filed Critical Lunan Pharmaceutical Group Corp
Priority to CN201310335239.XA priority Critical patent/CN104341433B/en
Publication of CN104341433A publication Critical patent/CN104341433A/en
Application granted granted Critical
Publication of CN104341433B publication Critical patent/CN104341433B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Abstract

The invention provides a kind of preparation method of prasugrel intermediate compound, this method includes the following steps:(1)Amido protecting reacts:4; 5,6,7 thiophanes simultaneously [3; 2 c] pyridine hydrochloride is raw material; target compound is obtained by halogenation, alkylated reaction, with sodium alkoxide deprotection reaction and HCl gas acidification reactions, this method is simple, and technique is advanced; the caused three wastes are few in production process; environmental protection pressure is small, and high income, suitable for industrialized production.

Description

A kind of preparation method of prasugrel intermediate
Technical field
A kind of medical synthesis field of the present invention, and in particular to preparation side of anti-platelet aggregation medicine prasugrel intermediate Method.
Background technology
Prasugrel(Prasugrel), chemical name:2- acetoxyl groups -5-(α-cyclopropyl carbonyl -2- luorobenzyls)- 4,5, 6,7- thiophanes simultaneously [3,2-c] pyridine, structural formula such as following formula(Ⅰ):
Prasugrel is as a kind of new oral anti-platelet aggregation medicine, by Japanese Sankyo companies and U.S. Eli The joint development development of Lilly companies, and in 2 Yue23Huo European Union approval listing in 2009.Research shows the prevention of prasugrel The effect of thrombus is stronger than the effect of clopidogrel, in experiments it is found that prasugrel can faster work, the trouble of prasugrel group Thrombus after person's medication in blood is fewer than clopidogrel group, and prasugrel is suppressing than the clopidogrel of approval dosage at present Effect in the cohesion of ADP induced platelets is more powerful, and the incidence of prasugrel group ischemic event reduces than clopidogrel group, general The effect that glug thunder antiplatelet is built up is obvious and rapid.And in the code name of prasugrel clinical research it is JUMBO-TIMI26 In second stage research, prasugrel faster and more unified inhibits blood platelet than chlorine Gray really.
Patent US4740510 and EP0542411 disclose a kind of preparation method of prasugrel, and its synthetic route is as follows:
Patent CN101402506 also discloses that a kind of preparation method of prasugrel, and its synthetic route is as follows:
In both the above method, 2- oxygen -2,4,5,6,7,7a- hexahydro thieno [3,2-c] pyridine hydrochloric acid are all employ Salt(Compound 1)Nucleophilic substitution occurs with adjacent luorobenzyl cyclopropyl ketone, is then acylated and obtains 2- acetoxyl groups -5-(a- Cyclopropyl carbonyl -2- luorobenzyls)- 4,5,6,7- thiophanes simultaneously [3,2-c] pyridine(Prasugrel)But the mesh of starting compound 1 Before can not conveniently obtain, can be bought without cheap industrial goods.
Patent US4740510 discloses its a kind of preparation method, and its synthetic route is as follows:
This method be by 4,5,6,7- thiophanes simultaneously [3,2-c] pyridine be initiation material at low temperature with n-BuLi, Butyl borate reacts to obtain 5- trityl -2- oxygen -2,4,5,6,7a- hexahydro thieno [3,2-c] pyridines, finally and formic acid Reaction obtains.Its reaction condition is harsher, it is necessary to -40 DEG C of low temperature, while normal-butyl reason is inflammable and explosive, can give extensive raw Production brings danger.
The system of 2- oxygen -2,4,5,6,7,7a- hexahydros thieno [3,2-c] pyridine hydrochloride is also disclosed that in EP192535 Preparation Method, but the step of patented method synthesis is more, yield is low, and synthesis cost is high, is unfavorable for the big production of lower industryization.
A kind of new intermediate for preparing prasugrel is disclosed in CN101245073A, but it selects benzyl protection, after Continuous deprotection steps will be very difficult.Structural formula is as follows:
For the defects of yield is low, cost is high, environmental protection pressure is big present in synthesis prasugrel at present, further research In high yield, inexpensive, green prasugrel synthetic method has wide market prospects, and this just needs to research and develop newly general Glug thunder intermediate, guarantee is provided to improve the synthetic method of prasugrel.
The content of the invention
It is an object of the invention to overcome the deficiencies of the prior art and provide a kind of prasugrel important intermediate formula (1) Preparation method.The structural formula of the prasugrel intermediate is as follows:
The preparation method of the present invention includes following steps:
1)Amido protecting reacts:Compound 1 and di-tert-butyl dicarbonate(BOC reagents)Reacted in dioxy naphthenic solvent Compound 2
2)Halogenation:Compound 2 occurs halogenation under halogenating agent effect and obtains compound 3
3)Alkylated reaction:Rudimentary sodium alkoxide below the carbon of compound 3 and six reacts to obtain compound 4, wherein R represent six carbon with Lower alkyl
4)Deprotection reaction:Compound 4 obtains compound 1 with HCl gas reactions
Above-mentioned steps 1), solvent used includes during reaction:Alcohol, esters, dioxy cycloalkanes, dichloromethane, tetrahydrofuran, Benzene, toluene, acetonitrile, DMF etc., preferably dioxy cycloalkanes, 60-100 DEG C of reaction temperature, preferable temperature are 80 DEG C.
Above-mentioned steps 2), halogenating agent used is CuCl during halogenation2Or CuBr2, preferably CuCl2, solvent for use is methanol.
Above-mentioned steps 3), sodium alkoxide used is the following sodium alkoxide of six carbon, and preferably sodium methoxide, solvent for use are methanol.
Above-mentioned steps 4), solvent for use is methanol, and HCl is the saturation methanol solution of the gas, and reaction terminates rear crude product and used Acetone, isopropyl ether are refined to obtain compound 1.
The beneficial effects of the present invention are:
Raw material used in the preparation method of the present invention is easy to get, while this method reaction condition is gentle, it is not necessary to ultralow Reacted under the conditions of temperature, it is safe suitable for large-scale industrial production without using inflammable and explosive reagent, and reaction yield is more Height, cost are lower.
Prasugrel intermediate disclosed by the invention(Compound 1), its preparation method is simple, and technique is advanced, production process In the caused three wastes it is few, environmental protection pressure is small, and high income, suitable for industrialized production.
Embodiment
Now beneficial effects of the present invention are further described by following examples, it is thus understood that these embodiments are only used for The purpose of illustration, is not limited the scope of the invention, at the same those of ordinary skill in the art according to the present invention done it is apparent Change and modification be also contained within the scope of the invention.
5- tertbutyloxycarbonyl -4,5,6,7- the thiophanes of embodiment 1 simultaneously [3,2-c] pyridine(Compound 2)Preparation:
By 4,5,6,7- thiophanes simultaneously [3,2-c] pyridine hydrochloride(Compound 5)12.6g adds 250ml three-necked flasks In, 150ml dioxane is added into three-necked flask, mechanical agitation is simultaneously dissolved quickly with warming-in-water, raw material, when temperature rises to 80 DEG C when, add 15.2gk2CO30.5h is stirred, di-tert-butyl dicarbonate 16.5g is added dropwise, continues stirring reaction 1h, stops reacting and be down to Room temperature, filtering, filtrate add 200ml ethyl acetate and 200ml ammoniacal liquor to stir, and liquid separation, ethyl acetate layer washing, salt are washed, dried, dense It is reduced to dry that 16.8g had both been compound 2.
The chloro- 5- tertbutyloxycarbonyls -4,5,6,7- thiophanes of the 2- of embodiment 2 simultaneously [3,2-c] pyridine(Compound 3)System It is standby:
Add 15.8g compounds 2 into 250ml three-necked flasks, add 200ml methanol stirring and dissolvings, add 5.6gCuCl2Continue to stir Reaction 4h is mixed, stops reacting, adds 200ml ethyl acetate and 300ml saturated sodium bicarbonate solutions to stir, liquid separation, ethyl acetate layer water Wash, salt is washed, dry, be concentrated to dryness 18.8g had both been compound 3
2- methoxyl group -5- tertbutyloxycarbonyl -4,5,6,7- the thiophanes of embodiment 3 simultaneously [3,2-c] pyridine(Compound 4) Preparation:
By 18g compounds 3,11.5g sodium methoxides are added in 250ml three-necked flasks, add 150ml methanol, magnetic agitation, in nitrogen 24h is heated to reflux under gas shielded, is cooled down, filtering, filtrate adds 200ml ethyl acetate and 300ml pure water to stir, liquid separation, acetic acid second Ester layer washing, salt are washed, dried, and are concentrated to dryness to obtain crude product, are crossed silicagel column purifying, are obtained 8.4g compounds 4.
Embodiment 4 2- oxygen -2,4,5,6,7,7a- hexahydros thieno [3,2-c] pyridine hydrochloride(Compound 1)System It is standby:
16g compounds 4 are dissolved in the homemade methanol hydrochloride solutions of 300ml, leads to HCl gases, 12h is stirred at room temperature, will Reaction solution is concentrated to dryness, and with 200ml acetone solutions, 400ml isopropyl ethers are added dropwise, has a large amount of crystal to separate out, filters, dries to obtain 6.5g Compound 1.

Claims (5)

  1. A kind of 1. preparation of hexahydro thieno [3,2-c] pyridine hydrochlorides of prasugrel intermediate 2- oxygen -2,4,5,6,7,7a one Method, it is characterised in that including following steps:
    1) amido protecting reacts:Compound 5 reacts to obtain chemical combination with di-tert-butyl dicarbonate in 1,4- dioxanes Thing 2
    2) halogenation:Compound 2 occurs halogenation under halogenating agent effect and obtains compound 3
    3) nucleophilic substitution:Compound 3 reacts to obtain compound 4 with sodium methoxide, and wherein R represents methyl
    4) deprotection reaction:Compound 4 leads to HCl gas reactions after dissolving and obtains compound 1
    Halogenating agent used in step 2) is copper chloride;
    Solvent used in step 3) is absolute methanol;
    Solvent used in step 4) is methanol hydrochloride solution.
  2. 2. preparation method as claimed in claim 1, it is characterised in that the reaction temperature of step 1) is 60-100 DEG C.
  3. 3. preparation method as claimed in claim 1, it is characterised in that the reaction temperature of step 1) is 80 DEG C.
  4. 4. preparation method as claimed in claim 1, it is characterised in that the solvent used in step 2) is methanol.
  5. 5. preparation method as claimed in claim 1, it is characterised in that step 4) is passed through HCl gases and keeps solution saturation.
CN201310335239.XA 2013-08-02 2013-08-02 A kind of preparation method of prasugrel intermediate Active CN104341433B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310335239.XA CN104341433B (en) 2013-08-02 2013-08-02 A kind of preparation method of prasugrel intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310335239.XA CN104341433B (en) 2013-08-02 2013-08-02 A kind of preparation method of prasugrel intermediate

Publications (2)

Publication Number Publication Date
CN104341433A CN104341433A (en) 2015-02-11
CN104341433B true CN104341433B (en) 2017-12-15

Family

ID=52497957

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310335239.XA Active CN104341433B (en) 2013-08-02 2013-08-02 A kind of preparation method of prasugrel intermediate

Country Status (1)

Country Link
CN (1) CN104341433B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740510A (en) * 1985-01-31 1988-04-26 Sanofi (S.A.) Derivatives of alpha-(2-oxo 2,4,5,6,7,7a-hexahydro thieno[3,2-c]5-pyridyl) phenyl acetic acid, and their use as platelet and thrombotic aggregation inhibitors
WO1999027929A1 (en) * 1997-12-04 1999-06-10 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CN101245073A (en) * 2008-03-21 2008-08-20 上海医药工业研究院 Medicine midbody and preparation method thereof
CN101985451A (en) * 2010-11-02 2011-03-16 北京赛科药业有限责任公司 Preparation method of prasugrel intermediate
CN102002056A (en) * 2010-11-02 2011-04-06 北京赛科药业有限责任公司 Method for preparing intermediate of prasugrel

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740510A (en) * 1985-01-31 1988-04-26 Sanofi (S.A.) Derivatives of alpha-(2-oxo 2,4,5,6,7,7a-hexahydro thieno[3,2-c]5-pyridyl) phenyl acetic acid, and their use as platelet and thrombotic aggregation inhibitors
WO1999027929A1 (en) * 1997-12-04 1999-06-10 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CN101245073A (en) * 2008-03-21 2008-08-20 上海医药工业研究院 Medicine midbody and preparation method thereof
CN101985451A (en) * 2010-11-02 2011-03-16 北京赛科药业有限责任公司 Preparation method of prasugrel intermediate
CN102002056A (en) * 2010-11-02 2011-04-06 北京赛科药业有限责任公司 Method for preparing intermediate of prasugrel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
盐酸普拉格雷合成路线图解;李素义 等;《中国医药工业杂志》;20101130;第41卷(第11期);第869-872页 *

Also Published As

Publication number Publication date
CN104341433A (en) 2015-02-11

Similar Documents

Publication Publication Date Title
CN104250232A (en) Preparation method of parecoxib sodium
CN105294653B (en) The preparation technology of Vonoprazan fumarate
CN103724261A (en) Novel industrial production method for hydroxychloroquine sulfate
CN106632244A (en) A novel synthetic method for preparing an anticancer medicine Niraparib
CN106496187A (en) A kind of synthetic method for preparing PARP inhibitor Niraparib
CN107778223B (en) Preparation method of betrixaban maleate
CN106008290A (en) Method for preparing tembotrions
CN109575014A (en) Benzimidazole simultaneously [2,1-a] isoquinolinone compound and preparation method thereof
CN109988077A (en) A kind of synthetic method and intermediate of A Palu amine
CN103159677B (en) The preparation method of IQL
CN106749259A (en) A kind of synthetic method of cyclopenta pyrimido azoles
CN105061405A (en) Preparation method of fimasartan potassium salt hydrate
CN104370935B (en) A kind of preparation method of bisulfate clopidogrel
CN109867673A (en) A method of synthesis Pabuk former times benefit cloth
CN104163786B (en) A kind of method preparing 5-methyl-3-bromo methyl cycloheptapyridine hydrobromate
CN106866707A (en) A kind of preparation method of benzimidazole simultaneously [2,1 b] thiazole
CN104341433B (en) A kind of preparation method of prasugrel intermediate
CN104311493A (en) Azoxystrobin synthesis method
CN104768936A (en) Enzalutamide polymorphic forms and its preparation
CN106588921B (en) A kind of synthetic method of the methyl formate of 7 azaindole 3
CN104829588B (en) A kind of Preparation Method And Their Intermediate of benzo [b] thiophene
CN107118088A (en) A kind of preparation method of m-hydroxy acetophenone
CN106749138B (en) A kind of preparation method of sulfuric acid Walla pa sand intermediate aldehydes
CN104163793A (en) Preparation method of roflumilast
CN106588786A (en) Preparation method of high purity favipiravir impurity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant